MORE►
Caris Life Sciences
Left: Milan Radovich, SVP and Chief Scientific Officer at Caris Life Sciences; Right: Boris L. Zaïtra, Head of Roche Corporate Business Development [Photos: LinkedIn/Roche]
North Texas’ Caris Life Sciences To Collaborate With Genentech on Novel Therapeutic Targets for Cancers
by Sandra Engelland | Dec 17, 2025
Under the terms of the agreement, Caris is eligible to receive upfront and near-term payments of $25 million and is also eligible for up to $1.1 billion of potential research, development, commercial, and net sales payments, as well as potential tiered royalties on net sales of collaboration therapies, the company said.
by Quincy Preston |
Sep 12, 2025
Dallas-Fort Worth-Arlington joins 30 metro areas driving two-thirds of the country's AI job market.
MORE►
by Quincy Preston and David Seeley |
Jun 18, 2025
The North Texas-based precision oncology firm raised $494 million in its IPO. Founder David Halbert is now a newly minted biotech billionaire worth an estimated $3.3 billion, Forbes reports.
MORE►
by David Seeley |
Jun 10, 2025
The Irving-based leader in precision oncology—which has raised $1.86 billion since 2018—plans to raise as much as $423.5 million when it goes public on the Nasdaq Global Select Market under the ticker symbol CAI.
MORE►
Eric Matthews, chief business officer, biopharma business development at Caris Life Sciences. [Photo: Caris Life Sciences]
Caris Life Sciences Appoints Chief Business Officer, Biopharma Business Development
by Lance Murray | May 8, 2025
Eric Matthews will provide strategic leadership to biopharma business development, and through his executive leadership, support Caris' expanding portfolio of biopharma partnerships, the company said.
MORE►
by Glenn Hunter |
Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
MORE►
by Lance Murray |
Apr 8, 2025
With the new funding, Caris said it has raised $1.86 billion in capital since 2018. Caris will use the raise to bring its science and technologies "to as many patients as possible and further our goal of revolutionizing precision medicine," Founder and CEO David Halbert said.
MORE►
by Nicole Ward, DRC Data Journalist |
Apr 3, 2025
Startup culture, higher ed, advanced tech, and quality of life drew them in—but what kept them here is more personal. Meet the 10 transplants who now call North Texas home. As one newcomer put it: “We’re living our best life in Texas.”
MORE►
David Spetzler, president of Caris Life Sciences [Image: Caris Life Sciences]
Caris Life Sciences Partners with Moderna To Advance mRNA-Based Cancer Drugs
by Lance Murray | Oct 24, 2023
Irving-based Caris said that via this multiyear agreement, Moderna will leverage Caris’ extensive library of de-identified, multimodal data solutions derived from whole exome sequencing, whole transcriptome sequencing, and protein analyses—along with claims data to improve development strategies for Moderna’s oncology pipeline.
MORE►
by Lance Murray |
Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Lance Murray |
Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
MORE►
DI People: Optic Gaming, Ziosk, Dr Pepper Keurig, and More Announce Leadership Moves
by Lance Murray | Oct 21, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Advent International, Stellar, Stream Realty Partners, The Citizenry, Sabre Corp., SB Architects, and others.
MORE►
by Lance Murray |
Sep 16, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Jacobs, HF Sinclair and Holly Energy Partners, Caris Life Sciences, Fossil Group, Deloitte, TRG, Invited, Instil Bio, RealPage, Critical Start, Genuine Article, and others.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Alex Edwards |
Oct 9, 2020
In this week's roundup of hires and promotions in North Texas, you'll also find news from NuZee, Imaginuity, HudsonLake, ALTO Real Estate Funds, AMN Healthcare, Caris Life Sciences, and more.
MORE►
